NFAT-133

N/A

Report date: 2023/02/11 10:58:47

Base Information

Drug NameNFAT-133
Drug Alias NameNFAT-33
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionImmunosuppressantsNuclear factor of activated T-cells cytoplasmic 1 inhibitors
TargetsNuclear factor of activated T-cells cytoplasmic 1
Therapy Area/IndicationsRejection of organ transplantationImmune System Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesAbbott Laboratories
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAbbott Laboratories
Active IndicationsN/A
Inactive IndicationsRejection of organ transplantationImmune System Diseases

Other Information

ATC CodeN/A
Related LinksN/A